Clinical Trial Update: Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study [NA]

View source ↗

Summary

Completed clinical trial evaluating the effects of rosiglitazone in combination with telmisartan on inflammatory markers and adipokines in type 2 diabetes patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Dr. Milan Gupta | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED